Literature DB >> 9226290

Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy.

R B Bestetti1, G Muccillo.   

Abstract

This investigation was carried out to compare the clinical course of patients with chronic Chagas' heart disease with that of patients with dilated cardiomyopathy. A total of 125 patients (75 chagasic and 50 nonchagasic) prospectively followed up at the Cardiomyopathy clinic of Santa Casa Hospital from January 1990 to June 1993 entered the study. Patients underwent clinical history, physical examination, serological tests, resting electrocardiogram, chest X-ray and two-dimensional echocardiography. In nonchagasic patients, hypertensive cardiomyopathy was found in 17 of 50 (34%) patients, idiopathic dilated cardiomyopathy in 16 (32%), the association of hypertension and coronary artery disease in 12 (24%) and ischemic cardiomyopathy in two (4%). Twenty-one (23%) chagasic and three (6%) nonchagasic patients died during the study period (P = 0.02). Sudden cardiac death occurred in eight (38%) chagasic patients, pump failure death was detected in 10 (47%) and the mode of death could not be determined in three (14%) patients with chronic Chagas' heart disease. Thus, patients with chronic Chagas' heart disease have a clinical course worse than that of patients with nonchagasic dilated cardiomyopathy. This fact may be ascribed to the electrocardiographic and morphological peculiarities usually found in chronic Chagas' heart disease.

Entities:  

Mesh:

Year:  1997        PMID: 9226290     DOI: 10.1016/s0167-5273(97)00083-1

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  33 in total

1.  Spontaneous heart disease in the adult chimpanzee (Pan troglodytes).

Authors:  Brittany M Seiler; Edward J Dick; Rodolfo Guardado-Mendoza; John L VandeBerg; Jeff T Williams; James N Mubiru; Gene B Hubbard
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

2.  Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.

Authors:  Christopher A Seid; Kathryn M Jones; Jeroen Pollet; Brian Keegan; Elissa Hudspeth; Molly Hammond; Junfei Wei; C Patrick McAtee; Leroy Versteeg; Amanda Gutierrez; Zhuyun Liu; Bin Zhan; Jonathan L Respress; Ulrich Strych; Maria Elena Bottazzi; Peter J Hotez
Journal:  Hum Vaccin Immunother       Date:  2016-10-13       Impact factor: 3.452

3.  Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy.

Authors:  Edecio Cunha-Neto; Victor J Dzau; Paul D Allen; Dimitri Stamatiou; Luiz Benvenutti; M Lourdes Higuchi; Natalia S Koyama; Joao S Silva; Jorge Kalil; Choong-Chin Liew
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

4.  Chagas Heart Failure in Patients from Latin America.

Authors:  Reinaldo B Bestetti
Journal:  Card Fail Rev       Date:  2016-11

Review 5.  Neuroparasitic infections: cestodes, trematodes, and protozoans.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

6.  Rapamycin Treatment Reduces Acute Myocarditis Induced by Trypanosoma cruzi Infection.

Authors:  Thabata L A Duque; Cynthia M Cascabulho; Gabriel M Oliveira; Andrea Henriques-Pons; Rubem F S Menna-Barreto
Journal:  J Innate Immun       Date:  2019-12-04       Impact factor: 7.349

Review 7.  Parasitic central nervous system infections in immunocompromised hosts.

Authors:  Melanie Walker; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-03-02       Impact factor: 9.079

Review 8.  Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives.

Authors:  Ilan Gottlieb; Robson Macedo; David A Bluemke; João A C Lima
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

9.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

Review 10.  Epidemiology of Chagas disease in Europe: many calculations, little knowledge.

Authors:  Jörn Strasen; Tatjana Williams; Georg Ertl; Thomas Zoller; August Stich; Oliver Ritter
Journal:  Clin Res Cardiol       Date:  2013-08-29       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.